The market was valued at $18.5 billion in 2011 and reached $19 billion in 2012.
The report also estimates 30 percent of all healthcare products currently under develop are combination devices with built-in pharmaceutical or biologic components.
Combination devices include orthopedic applications, coronary stents, photodynamic therapies and antimicrobial catheters.
More Articles on Devices:
Alphatec Spine Receives FDA Clearance for 2 Cervical, Fixation Devices
Zimmer Recall Labeled High Risk by FDA
Orthopedic Device Company DJO Global Acquires Exos Corp
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.